These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7212854)

  • 21. Pharmacokinetic study of aprindine and moxaprindine in dogs.
    de Suray JM; Lavis A; Breekpot F
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):209-15. PubMed ID: 7251236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A primer on pharmacokinetics.
    Quan DJ
    Nephrol Nurs J; 2008; 35(2):213-5. PubMed ID: 18472692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of pharmacokinetics in veterinary medicine. Article. II: Volume, clearance, and half-life.
    Martinez MN
    J Am Vet Med Assoc; 1998 Oct; 213(8):1122-7. PubMed ID: 9787378
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetic investigations of Craviten. III. Tissue distribution and elimination in rats.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):941-8. PubMed ID: 7243691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs.
    Kuroha M; Shirai Y; Shimoda M
    J Vet Pharmacol Ther; 2004 Oct; 27(5):355-9. PubMed ID: 15500574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Article V: clinically important errors in data interpretation.
    Martinez MN
    J Am Vet Med Assoc; 1998 Dec; 213(11):1564-9. PubMed ID: 9838954
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide].
    Witkowska M
    Kardiol Pol; 1981; 24(7):505-17. PubMed ID: 7024612
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections.
    Fura A; Khanna A; Vyas V; Koplowitz B; Chang SY; Caporuscio C; Boulton DW; Christopher LJ; Chadwick KD; Hamann LG; Humphreys WG; Kirby M
    Drug Metab Dispos; 2009 Jun; 37(6):1164-71. PubMed ID: 19251818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quinidine pharmacokinetics in patients with chronic right-ventricular circulatory failure complicated and not complicated by liver cirrhosis].
    Halawa B
    Pol Tyg Lek; 1984 Apr; 39(14):467-70. PubMed ID: 6473202
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetic analysis of intravenously and orally administered quinidine in cows.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Sep; 42(9):1482-7. PubMed ID: 7325456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical aspects of the fate of drugs in the body].
    Lazowski J; Rewerski W
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1595-600. PubMed ID: 6679083
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
    Bohlooli S; Keyhanfar F; Mahmoudian M
    Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cephalexin in calves after intravenous and subcutaneous administration.
    Garg SK; Chaudhary RK; Srivastava AK
    Acta Vet Hung; 1996; 44(2):195-201. PubMed ID: 8908743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody pharmacokinetics and pharmacodynamics.
    Wang W; Wang EQ; Balthasar JP
    Clin Pharmacol Ther; 2008 Nov; 84(5):548-58. PubMed ID: 18784655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cephalexin pharmacokinetics].
    Koroleva VG; Vasil'ev VK; Danilova VI; Firsov AA
    Antibiotiki; 1981 Mar; 26(3):113-6. PubMed ID: 7235651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal pharmacokinetics of the tumor necrosis factor receptor-immunoglobulin fusion protein lenercept and their extrapolation to humans.
    Richter WF; Gallati H; Schiller CD
    Drug Metab Dispos; 1999 Jan; 27(1):21-5. PubMed ID: 9884305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone-induced thyroid dysfunction.
    Porsche R; Brenner ZR
    Crit Care Nurse; 2006 Jun; 26(3):34-41; quiz 42. PubMed ID: 16717385
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of danofloxacin following intravenous and intramuscular administration in donkeys.
    Kum C; Gokbulut C; Sekkin S; Boyacioglu M
    J Vet Pharmacol Ther; 2009 Feb; 32(1):105-8. PubMed ID: 19161463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.